In a recent note to clients, Byron Capital's Healthcare and Biotech Analyst Douglas Loe reiterated his Speculative Buy target on Protox Therapeutics … [Read more...] about Byron Capital’s Douglas Loe: the Market is Undervaluing Protox Therapeutics
A year ago, the reasoning was air tight. Rare earth metals, that block of two rows of seventeen chemical elements at the bottom of the periodic table … [Read more...] about Neo Material Emerges as a Winner in the Rare Earths Space
Those who believed the savvy takeover of Edmonton's Chartwell Technologies was Amaya Gaming's (TSX:AYA) big play of 2011 were no doubt surprised … [Read more...] about Amaya Gaming Looks to Acquire Cryptologic
For Bioexx (TSX:BXI) shareholders, 2011 was a year to forget. Shuffling management, delays in bringing its Saskatchewan oilseed extraction plant up … [Read more...] about Is Bioexx a Takeover Candidate, or can it Rebound in 2012?
On December 30th, Open Text (TSX:OTC) Chairman Tom Jenkins, "for his innovative contributions to the development of the high technology industry..." … [Read more...] about Open Text Chairman Tom Jenkins receives The Order of Canada
When recounting the woes of Research in Motion in 2011, and there were many of them, the word Apple or iPhone usually didn't make it past paragraph … [Read more...] about New Samsung Galaxy phones are a shot across BlackBerry’s bow
2011 was Research in Motion's worst year. The company's entry into the tablet space, The BlackBerry Playbook, was widely regarded as a flop, and the … [Read more...] about Cantech Letter’s Top 10 Stories of 2011
There's value, and then there's valuation. Beleaguered Bombardier (TSX:BBD.B) investors know there is still value in the Canadian conglomerate, which … [Read more...] about Is Bombardier Ready to Rebound?
When American psychology professor Abraham Maslow created a visual aid in the form of a pyramid to underscore his now-famous Hierarchy of Needs theory … [Read more...] about Cantech Letter interviews Amiee Chan of Norsat
We have a winner. A panel of five judges; Tom Liston, Director of Research for Versant Partners, Barry Richards, Managing Director of Research for … [Read more...] about MOSAID, Cantech Letter’s 2011 Canadian Tech Stock of the Year